Cangrelor tetrasodium

Modify Date: 2024-01-11 20:06:53

Cangrelor tetrasodium Structure
Cangrelor tetrasodium structure
Common Name Cangrelor tetrasodium
CAS Number 163706-36-3 Molecular Weight 864.286
Density N/A Boiling Point 979ºC at 760 mmHg
Molecular Formula C17H21Cl2F3N5Na4O12P3S2 Melting Point N/A
MSDS N/A Flash Point 545.9ºC

 Use of Cangrelor tetrasodium


Cangrelor tetrasodium, an adenosine triphosphate analogue, is a reversible and selective platelet P2Y12 antagonist, with prompt and potent antiplatelet effects. Cangrelor tetrasodium directly blocks adenosine diphosphate (ADP)-induced activation and aggregation of platelets. Cangrelor tetrasodium is also a nonspecific GPR17 antagonist[1][2].

 Names

Name tetrasodium,[dichloro(phosphonato)methyl]-[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-oxidophosphoryl]oxyphosphinate
Synonym More Synonyms

 Cangrelor tetrasodium Biological Activity

Description Cangrelor tetrasodium, an adenosine triphosphate analogue, is a reversible and selective platelet P2Y12 antagonist, with prompt and potent antiplatelet effects. Cangrelor tetrasodium directly blocks adenosine diphosphate (ADP)-induced activation and aggregation of platelets. Cangrelor tetrasodium is also a nonspecific GPR17 antagonist[1][2].
Related Catalog
In Vitro Cangrelor tetrasodium is the only potent intravenous direct and specific adenosine diphosphate (ADP) P2Y12 receptor antagonist[1]. Cangrelor tetrasodium has pKb of 8.6-9.2 for hP2Y12 receptor[3].
In Vivo Cangrelor tetrasodium (10 mg/kg) not only significantly decreases BLM-induced release of inflammatory cytokines (PF4, CD40 L and MPO), but also decreases the increment of platelets, neutrophils and platelet-neutrophil aggregates in the fibrotic lung and in the peripheral blood of BLM-treated mice[2].
References

[1]. Bhattad VB, , et al. Intravenous cangrelor as a peri-procedural bridge with applied uses in ischemic events. Ann Transl Med. 2019;7(17):408.

[2]. Zhan T, Wei T, et al. Cangrelor alleviates bleomycin-induced pulmonary fibrosis by inhibiting platelet activation in mice. Mol Immunol. 2020;120:83-92.

[3]. Bekő K, et al. Contribution of platelet P2Y12 receptors to chronic Complete Freund's adjuvant-induced inflammatory pain. J Thromb Haemost. 2017;15(6):1223-1235.

 Chemical & Physical Properties

Boiling Point 979ºC at 760 mmHg
Molecular Formula C17H21Cl2F3N5Na4O12P3S2
Molecular Weight 864.286
Flash Point 545.9ºC
Exact Mass 862.876099
PSA 347.26000
LogP 4.67630
Vapour Pressure 0mmHg at 25°C
Storage condition -20℃

 Synonyms

Tetrasodium 5'-O-[({[dichloro(phosphonato)methyl]phosphinato}oxy)phosphinato]-N-[2-(methylsulfanyl)ethyl]-2-[(3,3,3-trifluoropropyl)sulfanyl]adenosine
Cangrelor tetrasodium
Adenosine, 5'-O-[[[(dichlorophosphonomethyl)hydroxyphosphinyl]oxy]hydroxyphosphinyl]-N-[2-(methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-, sodium salt (1:4)
UNII-2144G00Y7W
Cangrelor tetrasodium (USAN)
Top Suppliers:I want be here





Get all suppliers and price by the below link:

Cangrelor tetrasodium suppliers

Cangrelor tetrasodium price